{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:48:12Z","timestamp":1790102892802,"version":"4.0.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA023356"],"award-info":[{"award-number":["T32DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01 DA049665"],"award-info":[{"award-number":["K01 DA049665"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","award":["78477"],"award-info":[{"award-number":["78477"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Harm reduction services are inequitably accessible and efficient among people with a history of injection drug use (PWHID), particularly among those belonging to vulnerable communities. This systematic review identifies barriers and facilitators to accessing and adhering to harm reduction services among PWHID in priority populations to gain a deeper understanding of the intersectional barriers to these services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted using four databases (PubMed\/MEDLINE, Scopus, CINAHL, and Web of Science) to locate articles examining barriers and\/or facilitators associated with substance use harm reduction services among marginalized populations (e.g., racial\/ethnic minorities, sexual\/gender minorities, people living with HIV, veterans, etc.) in the United States. Study characteristics and key findings were extracted from studies and thematically analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This review identified 25 articles that examined factors associated with initiation and adherence to harm reduction services for PWHID. The harm reduction services most identified were medications for opioid use disorders (e.g., naloxone, buprenorphine) and syringe service programs. Factors were individual-level factors (e.g., motivation, stigma, previous negative experiences), as well as service-level barriers (e.g., accessibility, distance, setting). Many studies identified participant sociodemographic characteristics (e.g., race, age, sexuality) as a facilitator or barrier, although these factors are proxies for systemic and\/or structural barriers and should not necessarily be considered as intervention targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Incorporating harm reduction services as part of integrated, wraparound services in other healthcare settings may reduce barriers such as convenience, inaccessibility due to geography or transportation, stigma, and encourage service utilization as a result.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-025-01376-9","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T04:16:56Z","timestamp":1770869816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"given":"Carrie L.","family":"Nacht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Skaathun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Ogarrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reanna","family":"Durbin-Matrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristefer","family":"Stojanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1376_CR1","unstructured":"Ahmad FB CJ, Rossen LM, Sutton P. Provisional drug overdose death counts. Accessed 7 Apr 2025."},{"key":"1376_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RW, Egan JE, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14:1\u20139.","journal-title":"Harm Reduct J"},{"key":"1376_CR3","doi-asserted-by":"publisher","first-page":"749033","DOI":"10.3389\/fpubh.2022.749033","volume":"10","author":"S Puzhko","year":"2022","unstructured":"Puzhko S, Eisenberg MJ, Filion KB, et al. Effectiveness of interventions for prevention of common infections among opioid users: a systematic review of systematic reviews. Front Public Health. 2022;10:749033. https:\/\/doi.org\/10.3389\/fpubh.2022.749033.","journal-title":"Front Public Health"},{"issue":"23","key":"1376_CR4","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"1376_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.14664","volume":"114","author":"MA Irvine","year":"2019","unstructured":"Irvine MA, Kuo M, Buxton JA, et al. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction. 2019;114(9):1602\u201313. https:\/\/doi.org\/10.1111\/add.14664.","journal-title":"Addiction"},{"issue":"10","key":"1376_CR6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/ajph.2018.304590","volume":"108","author":"AL Pitt","year":"2018","unstructured":"Pitt AL, Humphreys K, Brandeau ML. Modeling health benefits and harms of public policy responses to the US opioid epidemic. Am J Public Health. 2018;108(10):1394\u2013400. https:\/\/doi.org\/10.2105\/ajph.2018.304590.","journal-title":"Am J Public Health"},{"key":"1376_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100031","author":"IJ Rao","year":"2021","unstructured":"Rao IJ, Humphreys K, Brandeau ML. Effectiveness of policies for addressing the US opioid epidemic: a model-based analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Region Health \u2013 Americas. 2021. https:\/\/doi.org\/10.1016\/j.lana.2021.100031.","journal-title":"Lancet Region Health \u2013 Americas"},{"issue":"6","key":"1376_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11524-020-00439-5","volume":"97","author":"L Dayton","year":"2020","unstructured":"Dayton L, Tobin K, Falade-Nwulia O, et al. Racial disparities in overdose prevention among people who inject drugs. J Urban Health. 2020;97(6):823\u201330. https:\/\/doi.org\/10.1007\/s11524-020-00439-5.","journal-title":"J Urban Health"},{"issue":"8","key":"1376_CR9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/add.12961","volume":"110","author":"C Rowe","year":"2015","unstructured":"Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110(8):1301\u201310. https:\/\/doi.org\/10.1111\/add.12961.","journal-title":"Addiction"},{"issue":"1","key":"1376_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-023-00736-7","volume":"20","author":"MR Khan","year":"2023","unstructured":"Khan MR, Hoff L, Elliott L, et al. Racial\/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduct J. 2023;20(1):24. https:\/\/doi.org\/10.1186\/s12954-023-00736-7.","journal-title":"Harm Reduct J"},{"issue":"19","key":"1376_CR11","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","volume":"388","author":"ML Barnett","year":"2023","unstructured":"Barnett ML, Meara E, Lewinson T, et al. Racial inequality in receipt of medications for opioid use disorder. N Engl J Med. 2023;388(19):1779\u201389. https:\/\/doi.org\/10.1056\/NEJMsa2212412.","journal-title":"N Engl J Med"},{"issue":"11","key":"1376_CR12","doi-asserted-by":"publisher","first-page":"e1002969","DOI":"10.1371\/journal.pmed.1002969","volume":"16","author":"AC Tsai","year":"2019","unstructured":"Tsai AC, Kiang MV, Barnett ML, et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019;16(11):e1002969.","journal-title":"PLoS Med"},{"key":"1376_CR13","doi-asserted-by":"publisher","first-page":"108918","DOI":"10.1016\/j.jsat.2022.108918","volume":"144","author":"JM Husain","year":"2023","unstructured":"Husain JM, Cromartie D, Fitzelle-Jones E, Brochier A, Borba CP, Montalvo C. A qualitative analysis of barriers to opioid agonist treatment for racial\/ethnic minoritized populations. J Subst Abuse Treat. 2023;144:108918.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"1376_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archpediatrics.2008.521","volume":"163","author":"K Rajakumar","year":"2009","unstructured":"Rajakumar K, Thomas SB, Musa D, Almario D, Garza MA. Racial differences in parents\u2019 distrust of medicine and research. Arch Pediatr Adolesc Med. 2009;163(2):108\u201314.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"1376_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s11606-008-0561-9","volume":"23","author":"K Armstrong","year":"2008","unstructured":"Armstrong K, McMurphy S, Dean LT, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23:827\u201333.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"1376_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/qje\/qjx029","volume":"133","author":"M Alsan","year":"2018","unstructured":"Alsan M, Wanamaker M. Tuskegee and the health of black men. Q J Econ. 2018;133(1):407\u201355.","journal-title":"Q J Econ"},{"key":"1376_CR17","doi-asserted-by":"publisher","first-page":"108105","DOI":"10.1016\/j.jsat.2020.108105","volume":"118","author":"M Pinedo","year":"2020","unstructured":"Pinedo M, Villatoro AP. The role of perceived treatment need in explaining racial\/ethnic disparities in the use of substance abuse treatment services. J Subst Abuse Treat. 2020;118:108105.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1376_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M18-3457","volume":"171","author":"T Beetham","year":"2019","unstructured":"Beetham T, Saloner B, Wakeman SE, Gaye M, Barnett ML. Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study. Ann Intern Med. 2019;171(1):1\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1376_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1370\/afm.2099","volume":"15","author":"CHA Andrilla","year":"2017","unstructured":"Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15(4):359\u201362.","journal-title":"Ann Fam Med"},{"key":"1376_CR20","doi-asserted-by":"crossref","unstructured":"Garnett MF MA. Drug overdose deaths in the United States, 2003\u20132023. National Center for Health Statistics. Accessed 7 April 2025.","DOI":"10.15620\/cdc\/170565"},{"key":"1376_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychires.2020.12.023","volume":"135","author":"B Rosner","year":"2021","unstructured":"Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Substance use among sexual minorities in the US \u2013 linked to inequalities and unmet need for mental health treatment? Results from the National Survey on Drug Use and Health (NSDUH). J Psychiatr Res. 2021;135:107\u201318. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.12.023.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1376_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/trgh.2019.0029","volume":"4","author":"JW Wanta","year":"2019","unstructured":"Wanta JW, Niforatos JD, Durbak E, Viguera A, Altinay M. Mental health diagnoses among transgender patients in the clinical setting: an all-payer electronic health record study. Transgend Health. 2019;4(1):313\u20135. https:\/\/doi.org\/10.1089\/trgh.2019.0029.","journal-title":"Transgend Health"},{"issue":"1","key":"1376_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13011-023-00581-8","volume":"19","author":"MM Paschen-Wolff","year":"2024","unstructured":"Paschen-Wolff MM, DeSousa A, Paine EA, Hughes TL, Campbell ANC. Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+\u2009people who use opioids and other drugs. Subst Abuse Treat Prev Policy. 2024;19(1):2. https:\/\/doi.org\/10.1186\/s13011-023-00581-8.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"3","key":"1376_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0740-5472(00)00114-8","volume":"19","author":"EL Lombardi","year":"2000","unstructured":"Lombardi EL, van Servellen G. Building culturally sensitive substance use prevention and treatment programs for transgendered populations. J Subst Abuse Treat. 2000;19(3):291\u20136. https:\/\/doi.org\/10.1016\/s0740-5472(00)00114-8.","journal-title":"J Subst Abuse Treat"},{"key":"1376_CR25","doi-asserted-by":"crossref","unstructured":"Collins PH. Black feminist thought: Knowledge, consciousness, and the politics of empowerment. routledge; 2022.","DOI":"10.4324\/9781003245650-2"},{"issue":"6","key":"1376_CR26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2307\/1229039","volume":"43","author":"K Crenshaw","year":"1991","unstructured":"Crenshaw K. Women of color at the center: selections from the third national conference on women of color and the law: mapping the margins: Intersectionality, identity politics, and violence against women of color. Stanf Law Rev. 1991;43(6):1241\u201379.","journal-title":"Stanf Law Rev"},{"key":"1376_CR27","unstructured":"Lorde A. Sister outsider: Essays and speeches. Crossing press; 2012."},{"key":"1376_CR28","unstructured":"Crenshaw K. Demarginalizing the intersection of race and sex: A black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. Feminist Legal Theories. Routledge; 2013:23\u201351."},{"key":"1376_CR29","unstructured":"Crenshaw KW. Mapping the margins: Intersectionality, identity politics, and violence against women of color. The public nature of private violence. Routledge; 2013:93\u2013118."},{"issue":"7","key":"1376_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2105\/AJPH.2012.300750","volume":"102","author":"L Bowleg","year":"2012","unstructured":"Bowleg L. The problem with the phrase women and minorities: intersectionality\u2014an important theoretical framework for public health. Am J Public Health. 2012;102(7):1267\u201373.","journal-title":"Am J Public Health"},{"issue":"4","key":"1376_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/089124395009004006","volume":"9","author":"PH Collins","year":"1995","unstructured":"Collins PH. Symposium: on West and Fenstermaker\u2019s \u201cdoing difference.\u201d Gend Soc. 1995;9(4):491\u20134.","journal-title":"Gend Soc"},{"key":"1376_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1376_CR33","unstructured":"Covidence systematic review software. 2024. www.covidence.org"},{"key":"1376_CR34","unstructured":"Elicit: The AI Research Assistant. 2024. www.elicit.com"},{"issue":"1","key":"1376_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12874-025-02528-y","volume":"25","author":"N Bernard","year":"2025","unstructured":"Bernard N, Sagawa JY, Bier N, Lihoreau T, Pazart L, Tannou T. Using artificial intelligence for systematic review: the example of elicit. BMC Med Res Methodol. 2025;25(1):75. https:\/\/doi.org\/10.1186\/s12874-025-02528-y.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"1376_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/15228959.2023.2224125","volume":"19","author":"S Whitfield","year":"2023","unstructured":"Whitfield S, Hofmann MA. Elicit: AI literature review research assistant. Public Serv Q. 2023;19(3):201\u20137. https:\/\/doi.org\/10.1080\/15228959.2023.2224125.","journal-title":"Public Serv Q"},{"issue":"4","key":"1376_CR37","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/cesm.70033","volume":"3","author":"J Bianchi","year":"2025","unstructured":"Bianchi J, Hirt J, Vogt M, Vetsch J. Data extractions using a large language model (Elicit) and human reviewers in randomized controlled trials: a systematic comparison. Cochrane Evid Synth Methods. 2025;3(4):e70033. https:\/\/doi.org\/10.1002\/cesm.70033.","journal-title":"Cochrane Evid Synth Methods"},{"issue":"5","key":"1376_CR38","doi-asserted-by":"publisher","first-page":"e35788","DOI":"10.1002\/cncr.35788","volume":"131","author":"LE Stamm","year":"2025","unstructured":"Stamm LE, Stojanovski K, Insalaco ME, Wright L, Kamen C, Fung C. Disparities in the cancer continuum experienced by transgender and gender-diverse patients: a rapid review. Cancer. 2025;131(5):e35788. https:\/\/doi.org\/10.1002\/cncr.35788.","journal-title":"Cancer"},{"key":"1376_CR39","unstructured":"Moola S MZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P,, Lisy K MP-F. Joanna Briggs Institute Reviewer's Manual. 2017. https:\/\/reviewersmanual.joannabriggs.org\/"},{"key":"1376_CR40","unstructured":"Moola S MZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P,, Lisy K MP-F. JBI Manual for Evidence Synthesis. 2020. https:\/\/synthesismanual.jbi.global\/"},{"key":"1376_CR41","unstructured":"Programme CAS. CASP Qualitative Studies Checklist [online]. 2023. Accessed August 12, 2025. https:\/\/casp-uk.net\/casp-tools-checklists\/qualitative-studies-checklist\/"},{"issue":"1","key":"1376_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12954-017-0146-1","volume":"14","author":"M Anastario","year":"2017","unstructured":"Anastario M, FourStar K, Ricker A, Dick R, Skewes MC, Rink E. A preliminary needs assessment of American Indians who inject drugs in northeastern Montana. Harm Reduct J. 2017;14(1):22. https:\/\/doi.org\/10.1186\/s12954-017-0146-1.","journal-title":"Harm Reduct J"},{"key":"1376_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.882421","author":"SB Bass","year":"2022","unstructured":"Bass SB, Kelly PJA, Pandit-Kerr S, et al. \u201cIt\u2019s my frenemy\u201d: a qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/fpubh.2022.882421.","journal-title":"Front Public Health"},{"issue":"5","key":"1376_CR44","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/10826084.2023.2177965","volume":"58","author":"ET Beidelman","year":"2023","unstructured":"Beidelman ET, Parker MA, Zoh RS, Owora AH. Service utilization among persons who inject drugs attending a syringe exchange program in New York State. Subst Use Misuse. 2023;58(5):649\u201356. https:\/\/doi.org\/10.1080\/10826084.2023.2177965.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"1376_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/16066359.2013.838225","volume":"22","author":"EE Bonar","year":"2014","unstructured":"Bonar EE, Rosenberg H. Injection drug users\u2019 perceived barriers to using self-initiated harm reduction strategies. Addict Res Theory. 2014;22(4):271\u20138. https:\/\/doi.org\/10.3109\/16066359.2013.838225.","journal-title":"Addict Res Theory"},{"issue":"1","key":"1376_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/00952999309002668","volume":"19","author":"ML Brecht","year":"1993","unstructured":"Brecht ML, Anglin MD, Wang JC. Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. Am J Drug Alcohol Abuse. 1993;19(1):89\u2013106. https:\/\/doi.org\/10.3109\/00952999309002668.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"1376_CR47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1080\/10826084.2022.2083171","volume":"57","author":"TA Chueng","year":"2022","unstructured":"Chueng TA, Tookes HE, McLaughlin M, Arcaro-Vinas AM, Serota DP, Bartholomew TS. Injection and sexual behavior profiles among people who inject drugs in Miami, Florida. Subst Use Misuse. 2022;57(9):1374\u201382. https:\/\/doi.org\/10.1080\/10826084.2022.2083171.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"1376_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.drugpo.2009.12.006","volume":"21","author":"EC Costenbader","year":"2010","unstructured":"Costenbader EC, Zule WA, Coomes CC. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales. Int J Drug Policy. 2010;21(5):425\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2009.12.006.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"1376_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","volume":"22","author":"J Gryczynski","year":"2013","unstructured":"Gryczynski J, Jaffe JH, Schwartz RP, et al. Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. Am J Addict. 2013;22(3):285\u201391. https:\/\/doi.org\/10.1111\/j.1521-0391.2012.12004.x.","journal-title":"Am J Addict"},{"issue":"4","key":"1376_CR50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jsat.2011.06.005","volume":"41","author":"J Gryczynski","year":"2011","unstructured":"Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH. Patterns in admission delays to outpatient methadone treatment in the United States. J Subst Abuse Treat. 2011;41(4):431\u20139. https:\/\/doi.org\/10.1016\/j.jsat.2011.06.005.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"1376_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/nur.22355","volume":"47","author":"O Heidari","year":"2024","unstructured":"Heidari O, Winiker A, Dangerfield DT, et al. Understanding healthcare engagement for people who inject drugs. Res Nurs Health. 2024;47(2):242\u201350. https:\/\/doi.org\/10.1002\/nur.22355.","journal-title":"Res Nurs Health"},{"key":"1376_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.208986","author":"AA Jones","year":"2023","unstructured":"Jones AA, Schneider KE, Tobin KE, O\u2019Sullivan D, Latkin CA. Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: findings on marginalized populations. J Subst Use Addict Treat. 2023. https:\/\/doi.org\/10.1016\/j.josat.2023.208986.","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"1376_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1353\/hpu.2006.0063","volume":"17","author":"SY Kang","year":"2006","unstructured":"Kang SY, Goldstein MF, Deren S. Health care utilization and risk behaviors among HIV positive minority drug users. J Health Care Poor Underserved. 2006;17(2):265\u201375. https:\/\/doi.org\/10.1353\/hpu.2006.0063.","journal-title":"J Health Care Poor Underserved"},{"issue":"12","key":"1376_CR54","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.drugpo.2015.08.013","volume":"26","author":"NJ Kim","year":"2015","unstructured":"Kim NJ, Jin H, McFarland W, Raymond HF. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005\u20132012. Int J Drug Policy. 2015;26(12):1238\u201343. https:\/\/doi.org\/10.1016\/j.drugpo.2015.08.013.","journal-title":"Int J Drug Policy"},{"key":"1376_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00676-8","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Allen ST, Schneider KE, et al. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs. Harm Reduct J. 2022. https:\/\/doi.org\/10.1186\/s12954-022-00676-8.","journal-title":"Harm Reduct J"},{"key":"1376_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.drugalcdep.2017.06.009","volume":"178","author":"N Krawczyk","year":"2017","unstructured":"Krawczyk N, Feder KA, Fingerhood MI, Saloner B. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend. 2017;178:512\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.06.009.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1376_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5820\/aian.2701.2020.64","volume":"27","author":"J Leston","year":"2020","unstructured":"Leston J, Crisp C, Lee MC, Rink E. Interviews with American Indian and Alaska Native people who inject drugs. Am Indian Alsk Native Ment Health Res. 2020;27(1):64\u201385. https:\/\/doi.org\/10.5820\/aian.2701.2020.64.","journal-title":"Am Indian Alsk Native Ment Health Res"},{"issue":"1","key":"1376_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10461-009-9614-2","volume":"15","author":"AN Martinez","year":"2011","unstructured":"Martinez AN, Bluthenthal RN, Flynn NM, Anderson RL, Kral AH. HIV risks and seroprevalence among Mexican American injection drug users in California. AIDS Behav. 2011;15(1):95\u2013102. https:\/\/doi.org\/10.1007\/s10461-009-9614-2.","journal-title":"AIDS Behav"},{"issue":"1","key":"1376_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12954-023-00891-x","volume":"20","author":"S Nolen","year":"2023","unstructured":"Nolen S, Trinidad AJ, Jordan AE, et al. Racial\/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City. Harm Reduct J. 2023;20(1):152. https:\/\/doi.org\/10.1186\/s12954-023-00891-x.","journal-title":"Harm Reduct J"},{"issue":"6","key":"1376_CR60","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/10826084.2022.2046097","volume":"57","author":"G Pro","year":"2022","unstructured":"Pro G, Liebert M, Remiker M, Sabo S, Montgomery BEE, Zaller N. Homeless opioid treatment clients transitioning to dependent and independent housing: differential outcomes by Race\/Ethnicity. Subst Use Misuse. 2022;57(6):867\u201375. https:\/\/doi.org\/10.1080\/10826084.2022.2046097.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"1376_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1300\/J233v05n02_02","volume":"5","author":"GL Reynolds","year":"2006","unstructured":"Reynolds GL, Wells RS, Fisher DG, Cagle HH. Health services usage by Alaskan injection drug users. J Ethn Subst Abuse. 2006;5(2):23\u201334. https:\/\/doi.org\/10.1300\/J233v05n02_02.","journal-title":"J Ethn Subst Abuse"},{"key":"1376_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00868-w","author":"K Salow","year":"2023","unstructured":"Salow K, Jack HE, Tinsley J, et al. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys. Harm Reduct J. 2023. https:\/\/doi.org\/10.1186\/s12954-023-00868-w.","journal-title":"Harm Reduct J"},{"key":"1376_CR63","doi-asserted-by":"publisher","first-page":"111293","DOI":"10.1016\/j.drugalcdep.2024.111293","volume":"259","author":"S Shrestha","year":"2024","unstructured":"Shrestha S, Stopka TJ, Hughto JMW, et al. LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: a structural equation model analysis among people who use drugs in Massachusetts. Drug Alcohol Depend. 2024;259:111293. https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111293.","journal-title":"Drug Alcohol Depend"},{"issue":"6-7","key":"1376_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1081\/ja-100104088","volume":"36","author":"CJ VanderWaal","year":"2001","unstructured":"VanderWaal CJ, Washington FL, Drumm RD, Terry YM, McBride DC, Finley-Gordon RD. African-American injection drug users: tensions and barriers in HIV\/AIDS prevention. Subst Use Misuse. 2001;36(6\u20137):735\u201355. https:\/\/doi.org\/10.1081\/ja-100104088.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"1376_CR65","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2105\/ajph.2008.158337","volume":"100","author":"CT Williams","year":"2010","unstructured":"Williams CT, Metzger DS. Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. Am J Public Health. 2010;100(6):1068\u201374. https:\/\/doi.org\/10.2105\/ajph.2008.158337.","journal-title":"Am J Public Health"},{"key":"1376_CR66","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221118462","author":"A Farhoudian","year":"2022","unstructured":"Farhoudian A, Razaghi E, Hooshyari Z, et al. Barriers and facilitators to substance use disorder treatment: an overview of systematic reviews. Subst Abuse. 2022. https:\/\/doi.org\/10.1177\/11782218221118462.","journal-title":"Subst Abuse"},{"issue":"1","key":"1376_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12954-024-01063-1","volume":"21","author":"K Beck","year":"2024","unstructured":"Beck K, Pallot K, Amri M. A scoping review on barriers and facilitators to harm reduction care among youth in British Columbia, Canada. Harm Reduct J. 2024;21(1):189. https:\/\/doi.org\/10.1186\/s12954-024-01063-1.","journal-title":"Harm Reduct J"},{"issue":"19","key":"1376_CR68","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.3390\/ijerph181910219","volume":"18","author":"LB Selseng","year":"2021","unstructured":"Selseng LB, Follev\u00e5g B-M, Aaslund H. How people with lived experiences of substance use understand and experience user involvement in substance use care: a synthesis of qualitative studies. Int J Environ Res Public Health. 2021;18(19):10219.","journal-title":"Int J Environ Res Public Health"},{"issue":"3 Suppl","key":"1376_CR69","first-page":"11s","volume":"93","author":"WM Byrd","year":"2001","unstructured":"Byrd WM, Clayton LA. Race, medicine, and health care in the United States: a historical survey. J Natl Med Assoc. 2001;93(3 Suppl):11s\u201334s.","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"1376_CR70","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1370\/afm.2792","volume":"20","author":"E Lett","year":"2022","unstructured":"Lett E, Asabor E, Beltr\u00e1n S, Cannon AM, Arah OA. Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. Ann Fam Med. 2022;20(2):157\u201363. https:\/\/doi.org\/10.1370\/afm.2792.","journal-title":"Ann Fam Med"},{"issue":"2","key":"1376_CR71","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ajog.2022.03.011","volume":"227","author":"A Hauspurg","year":"2022","unstructured":"Hauspurg A, Jeyabalan A. The risk factor is racism, not race. Am J Obstet Gynecol. 2022;227(2):358\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2022.03.011.","journal-title":"Am J Obstet Gynecol"},{"key":"1376_CR72","unstructured":"Studies JCfH. The state of the nation\u2019s housing 2020. 2020. Accessed 28 Aug 2025. https:\/\/www.jchs.harvard.edu\/sites\/default\/files\/reports\/files\/Harvard_JCHS_The_State_of_the_Nations_Housing_2020_Report_Revised_120720.pdf"},{"key":"1376_CR73","unstructured":"Bureau USC. DP04: Selecting Housing Characteristics. 2024. Accessed 28 Aug 2025. https:\/\/data.census.gov\/table?q=DP04"},{"issue":"1","key":"1376_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1525-1497.2005.00278.x","volume":"21","author":"MB Kushel","year":"2006","unstructured":"Kushel MB, Gupta R, Gee L, Haas JS. Housing instability and food insecurity as barriers to health care among low-income americans. J Gen Intern Med. 2006;21(1):71\u20137. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.00278.x.","journal-title":"J Gen Intern Med"},{"issue":"10117","key":"1376_CR75","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","volume":"391","author":"RW Aldridge","year":"2018","unstructured":"Aldridge RW, Story A, Hwang SW, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(17)31869-X.","journal-title":"Lancet"},{"key":"1376_CR76","doi-asserted-by":"publisher","first-page":"107076","DOI":"10.1016\/j.addbeh.2021.107076","volume":"123","author":"AE Austin","year":"2021","unstructured":"Austin AE, Shiue KY, Naumann RB, Figgatt MC, Gest C, Shanahan ME. Associations of housing stress with later substance use outcomes: a systematic review. Addict Behav. 2021;123:107076. https:\/\/doi.org\/10.1016\/j.addbeh.2021.107076.","journal-title":"Addict Behav"},{"issue":"1","key":"1376_CR77","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12889-015-1479-x","volume":"15","author":"R Zivanovic","year":"2015","unstructured":"Zivanovic R, Milloy MJ, Hayashi K, et al. Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health. 2015;15(1):106. https:\/\/doi.org\/10.1186\/s12889-015-1479-x.","journal-title":"BMC Public Health"},{"issue":"3","key":"1376_CR78","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugpo.2009.10.010","volume":"21","author":"JF Kelly","year":"2010","unstructured":"Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202\u20137. https:\/\/doi.org\/10.1016\/j.drugpo.2009.10.010.","journal-title":"Int J Drug Policy"},{"key":"1376_CR79","doi-asserted-by":"publisher","DOI":"10.59586\/jsrc.v11i1.466","author":"H Terence","year":"2025","unstructured":"Terence H, Bhavana P, Elizabeth M, et al. Model for providing wrap-around care for patients with substance use disorders at a single-site, urban student-run free clinic. J Stud-Run Clin. 2025. https:\/\/doi.org\/10.59586\/jsrc.v11i1.466.","journal-title":"J Stud-Run Clin"},{"key":"1376_CR80","unstructured":"Campbell S W, Sattler V, Wood N K, & Smart D (2021) Hospital-based harm reduction interventions: a systematic review.\u00a0Int J Nurs Stud Scholarsh, 8(58)"}],"updated-by":[{"DOI":"10.1186\/s12954-026-01495-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000}}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01376-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:40:51Z","timestamp":1782844851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01376-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01376-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The Figure 2 has been removed in the article PDF.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12954-026-01495-x","URL":"https:\/\/doi.org\/10.1186\/s12954-026-01495-x","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}